NCT00347139View on ClinicalTrials.gov

Repeat Doses Of A New Medication (GW642444) In Asthmatic Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

May 23, 2006

Primary Completion Date

January 10, 2007

Study Completion Date

January 10, 2007

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

GW642444 (25, 100 & 400 mcg/day)

25, 100 and 400mcg/dose

DRUG

Salmeterol 50mcg

Salmeterol 50mcg

Trial Locations (7)

6035

GSK Investigational Site, Wellington

22927

GSK Investigational Site, Großhansdorf

65187

GSK Investigational Site, Wiesbaden

105 077

GSK Investigational Site, Moscow

SE-413 45

GSK Investigational Site, Gothenburg

SE-141 86

GSK Investigational Site, Stockholm

SE5 9RJ

GSK Investigational Site, London

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00347139 - Repeat Doses Of A New Medication (GW642444) In Asthmatic Patients | Biotech Hunter | Biotech Hunter